Faculty of Medicine, Hebrew University of Jerusalem, Digestive Diseases Institute, Shaare-Zedek Medical Center, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Oncology Department, Shaare-Zedek Medical Center, Jerusalem, Israel.
World J Surg Oncol. 2021 Dec 8;19(1):341. doi: 10.1186/s12957-021-02452-7.
Early detection of colorectal cancer (CRC) improves prognosis, yet many CRCs are diagnosed following symptoms. The aim of this study was to determine which CRC-related symptoms or signs can predict an advanced CRC in the pre-operative stage.
Retrospective analysis of 300 patients who underwent surgery for CRC between the years 2008 and 2019. Patients' symptoms prior to CRC diagnosis were documented. Primary endpoint was the association of signs or/and symptoms with CRC diagnosis at TNM stages of 2-4 (i.e., highly advanced), compared to TNM score of 0-1 (i.e., locally advanced).
Three hundred patients, 91 with locally advanced and 209 with highly advanced CRC, were enrolled. There was a significant correlation between highly advanced CRC, compared to locally advanced, regarding tumor size (4.8 vs. 2.6 cm, p<0.001), presentation of any symptom prior to diagnosis (77% vs. 54%, p<0.001), anemia (46% vs. 29%, p=0.004), and severe anemia (17% vs. 4%, p=0.002). Mean hemoglobin was 12.2 ± 2.2 and 13.1 ± 1.8 in the highly advanced compared to locally advanced CRC, respectively, p<0.001. Anemia correlated with the T stage of the tumor: 21% of patients diagnosed at stages 0-1 had anemia, 39% at stage 2, 44% at stage 3, and 66% at stage 4 (p=0.001).
Anemia is the only finding that correlates with highly advanced CRC, in the pre-operative stage. When CRC has been diagnosed, the presence of anemia, at any level, may be considered in determining prognosis at the pre-operative stage. Physicians should be aware that when anemia is present, the risk for highly advanced CRC increases, and therefore should pursue with CRC detection.
结直肠癌(CRC)的早期发现可改善预后,但许多 CRC 是在出现症状后才被诊断出来的。本研究旨在确定哪些 CRC 相关症状或体征可以在术前阶段预测 CRC 的晚期。
回顾性分析 2008 年至 2019 年间接受 CRC 手术的 300 例患者。记录患者在 CRC 诊断前的症状。主要终点是与 TNM 分期 2-4 期(即高度晚期)相比,体征或/和症状与 CRC 诊断的相关性,TNM 评分 0-1 期(即局部晚期)。
共纳入 300 例患者,其中 91 例为局部晚期 CRC,209 例为高度晚期 CRC。与局部晚期 CRC 相比,高度晚期 CRC 的肿瘤大小(4.8cm 比 2.6cm,p<0.001)、诊断前出现任何症状(77%比 54%,p<0.001)、贫血(46%比 29%,p=0.004)和严重贫血(17%比 4%,p=0.002)的相关性更为显著。高度晚期 CRC 的平均血红蛋白水平为 12.2 ± 2.2,局部晚期 CRC 为 13.1 ± 1.8,p<0.001。贫血与肿瘤的 T 分期相关:0-1 期诊断的患者中 21%有贫血,2 期为 39%,3 期为 44%,4 期为 66%(p=0.001)。
贫血是术前阶段与高度晚期 CRC 唯一相关的发现。当 CRC 被诊断时,无论贫血程度如何,都可在术前阶段考虑用于预测预后。医生应意识到,当存在贫血时,高度晚期 CRC 的风险增加,因此应积极进行 CRC 检测。